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ABSTRACT
Introduction: In the case of clinically negative inguinal regions in penile cancer, the treatments proposed might vary from 
careful observation to radical dissection for all patients. We evaluated the effectiveness of the sentinel lymph node biopsy 
using lymphoscintigraphy in patients with penile cancer and at least one negative inguinal region.
Materials and Methods: In 18 patients, biopsy of the sentinel lymph node from the 32 negative inguinal regions and modified 
radical lymphadenectomy in these regions regardless of the biopsy results was performed. Clinical staging, pathological 
results of the sentinel and the other lymph nodes removed during lymphadenectomy, tumor behavior, local and inguinal 
recurrence and specific disease mortality were accessed.
Results: The mean age of the study sample was 57.7 years (44 - 81 years) and the sentinel lymph node presented 0% false 
negative 66% sensitivity, and 79.3% specificity when compared with the modified inguinal lymphadenectomy as the gold 
standard treatment.
Conclusion: Sentinel lymph node biopsy is a feasible method of assessing the presence of regional metastasis in patients 
with penile cancer and clinically negative inguinal regions. However, the optimal lymphoscintigraphy technique is still in 
evolution and requires further optimization at high volume centers.
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INTRODUCTION
 While penile cancer is a rare disease in devel-
oped countries, its rate in underdeveloped countries 
is in fact the contrary (1). Disease treatment becomes 
a challenge when procedures related to prophylactic 
dissection of regional lymph nodes are evaluated.
 When lymphatic metastasis in the inguinal 
region is clinically evident, classical radical lymph 
node dissection is the recommended treatment for 
improved overall survival and quality of life (1).
 Lopes et al. comparing clinical and pathologi-
cal features in penile cancer patients, found that the 
sensitivity, specificity, positive and negative predic-
tive values, and effectiveness of clinical procedures 
 Clinical Urolo�y 
for assessment of metastases were 66.7, 52.3, 60.8, 
58.6 and 59.9%, respectively. On multivariate analy-
sis of pathological factors only lymphatic (p = 0.0008) 
and venous (p = 0.0410) penile embolizations were 
significantly associated with risk of lymph node me-
tastases (2).
 In the case of clinically negative inguinal 
regions, the treatments proposed might vary from 
careful observation to radical dissection for all pa-
tients with intermediary solutions such as sentinel 
lymph node biopsy and modified dissection of the 
inguinal region with preservation of some structures 
and lymph nodes (3).
 The principle of identifying the first drain-
age lymph node in the affected area and based on its 
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pathological assessment defining the need for more 
aggressive interventions seems to be an important 
and interesting procedure. This may be the reason 
why it has been the subject of several articles that 
demonstrate experience in this procedure or aim at 
assessing the validity of this test and its morbidity in 
relation to other interventions (4,5).
 The purpose of our study is to evaluate the 
effectiveness of the sentinel lymph node biopsy using 
lymphoscintigraphy in patients with penile cancer and 
at least one negative inguinal region.
MATERIALS AND METHODS
 A prospective study on 18 patients who had 
penile cancer and at least one clinically negative in-
guinal region was conducted between May 2000 and 
July 2005. This study was approved by Institutional 
Review Board.
 All the patients, after signature of informed 
consent, had undergone partial penectomy, biopsy of 
the sentinel lymph node from the negative inguinal 
regions and modified radical lymphadenectomy as 
proposed by Catalona (1988) in these regions regard-
less of the biopsy results (3).
 Biopsy of the sentinel lymph node and classi-
cal radical lymphadenectomy were performed in the 
positive inguinal regions.
 Patients were classified according to surgical 
staging and histological level based on the TNM 2002 
system proposed by the UICC/AJCC (6).
 Patients underwent lymphoscintigraphy 
with 99mtechnetium-labelled nanocolloid, which was 
injected intradermally around the tumor or into the 
distal penile shaft skin.
 Four hours later, the sentinel lymph node 
was identified during surgery using a hand-held 
γ-probe. Complementary methods such as the peri 
lesion methylene blue injection were not used in this 
protocol.
 Data assessment included clinical staging, 
pathological results of the sentinel lymph node and the 
other lymph nodes removed during modified lymph-
adenectomy as well as post-surgical tumor behavior, 
verifying local and inguinal recurrence and specific 
disease mortality.
RESULTS
 The mean age of the study sample was 57.7 
years (44 - 81 years) and the initial clinical assessment 
revealed that four patients had a positive inguinal 
region, which left 32 inguinal regions to be studied 
using the proposed method as clinically affected re-
gions were excluded from the study.
 In 6 of the 32 inguinal regions studied, the 
lymphoscintigraphy did not detect the sentinel lymph 
node when the gamma camera and the intraoperative 
portable probe were used, which meant that 26 ingui-
nal regions with sentinel lymph nodes were identified 
and a total of 52 lymph nodes were removed at this 
stage. It should be underscored that one of the six 
undetected lymph node inguinal regions was in a pa-
tient with a clinically contralateral positive inguinal 
region.
 The results of the pathological study of the 
sentinel lymph nodes revealed that only two ingui-
nal regions of the 26 regions studied were affected 
(7.7%).
 It should be emphasized that of these two 
clinically negative regions with positive sentinel 
lymph nodes, one of them was in a patient with a 
clinically positive contralateral inguinal region.
 When the pathological study results of the 
modified lymph node dissection specimens in 32 
clinically negative inguinal regions were assessed, 
three were found to be positive. The positive result 
indicated the need for radical procedure.
 Two of them were from inguinal regions with 
positive sentinel lymph nodes and one was found 
among the six clinically negative inguinal regions 
without sentinel lymph node detection. Furthermore, 
one of the two positive sentinel nodes was the only 
positive nodes in this dissection. They were 0.8 and 
0.6 cm large and the total of node dissected in theses 
regions were 7 and 10, respectively.
 In the 24 inguinal regions with negative sen-
tinel lymph node, no diagnostic changes occurred in 
any of them during lymph node dissection. Therefore, 
when we compared this method with the modified 
inguinal lymphadenectomy as the gold standard treat-
ment, we found these values: 0% false negative, 66% 
sensitivity and 79.3% specificity. It is important to 
highlight that this false negative rate does not consider 
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the patient without detection of sentinel lymph node 
and positive lymphatic dissection.
 Some more relevant data can be cited: a total 
of 297 lymph nodes were dissected, 157 on the right 
and 140 on the left, a mean number of 8.25 lymph 
nodes per region studied.
 A study of the dissected lymph nodes con-
firmed the diagnosis of regional metastasis in all four 
clinically positive regions. Moreover, in all the pa-
tients who underwent classical radical dissection due 
to lymph node positivity, the positivity of the lymph 
nodes removed did not surpass the limits proposed by 
the modified dissection technique.
 In four clinical positive regions, we found 10 
positive nodes out of 35 dissected. These were mean 
2.2 cm large and none was adhered to the adjacent 
tissues.
 An evaluation of the distribution of these 
patients according to staging and histological grade 
revealed that six patients were pT1G1, 8 were pT2G1, 
3 were pT2G2 and 1 was pT3G3. Metastasis was not 
detected in patients with T1 primary lesions.
 The follow-up period ranged from 8 to 
58 months, with a mean follow-up period of 28.3 
months.
 Two patients presented regional disease 
recurrence that was confirmed by the pathological 
exam and both patients presented positive surgical 
staging for metastasis in the inguinal regions. Both 
patients died two and four months after recurrence. 
These patients had presented with positive groins 
at initial diagnosis and were submitted to radical 
lymphadenectomy.
 Another 81-year-old patient died three months 
after surgery but the cause was not directly related to 
the disease.
 Table-1 demonstrates the above-described 
results.
COMMENTS
 The literature demonstrates that after resec-
tion, 20% of clinically negative inguinal regions in 
patients with penile cancer have proved to be positive 
(7). This data underscores the importance of proposing 
some kind of treatment for patients in this condition, 
especially since prognosis is poor in patients with 
delayed diagnosis of lymph node metastasis (8).
 Neglected regional adenopathy is not uncom-
mon in underdeveloped countries after penile cancer 
treatment and in advanced cases, the inguinal mass 
can reach large sizes and little can be offered as a 
curative treatment (9).
 Considering that groin is the first site of 
lymphatic dissemination of penile squamous cell 
carcinoma , inguinal involvement is one of the most 
important factors in survival prognosis and it is very 
common to lost follow-up of these patients in un-
derdeveloped countries, we offer lymphadenectomy 
concomitant to penectomy in our institution (9).
 On the other hand, lymph node dissection in the 
inguinal region can cause up to 80% morbidity (10,11). 
A better assessment can be obtained with a biopsy of 
a single or small group of sentinel lymph nodes as it 
allows for finer sections of the specimen and an im-
munohistochemical study whenever required (5).
 In view of the fact that in 50% of positive 
cases, the sentinel lymph node was the only lymph 
node affected after ample dissection, it has been sug-
gested that on the basis of parameters such as size of 
metastasis and histological grade of cell differentia-
tion, only the sentinel lymph node should be removed 
even when it is positive (8,12).
 Our study demonstrated that in two cases 
of sentinel lymph node positivity, the disease was 
restricted only to the sentinel lymph node in one 
case.
 Another significant data was the false nega-
tive percentage, which in our study was 0% but in 
the literature is approximately 11 to 18% (4,5,13). 
We could have obtained similar results if the study 
sample was larger.
 However, there were no cases of sentinel 
lymph node detection by the gamma camera without 
confirmation by the intraoperative portable probe, 
but in conformity occurred in 30% of the cases in the 
literature (4). This may be due to a technical change 
brought about by the lymphoscintigraphy, which 
was performed on the same morning as the surgery, 
indicating that the probe was used a few hours after 
the initial exam. Moreover, this technical change 
eliminated the need for a complementary exam with 
methylene blue (14,15).
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 Other noninvasive procedures have been used 
to detect inguinal metastases for penile cancer, includ-
ing the use of lymphotropic nanoparticles enhanced 
magnetic resonance imaging (16).
 Recently Horenblas et al. studied 50 patients 
with penile cancer and negative groins. These patients 
were submitted to SPEC-CT and lymphoscintigraphy 
utilizing the Daseler’s five zones, that divide the groin 
region in four quadrants and one central zone on sa-
pheno-femoral junction, they found that all sentinel 
nodes were in superior or central zones. In conclusion, 
they suggested that the dissection should be limited 
on and above the sapheno-femoral junction (17).
 Some authors of Latin America have pro-
posed endoscopic inguinal lymphadenectomy with 
decreased surgical morbidity, such as skin necrosis, 
wound infections and lymphedema. Although new 
endoscopic approaches to perform inguinal lymph-
adenectomy may decrease postoperative morbidity 
without compromising oncological control, sentinel 
lymph node biopsy may help improve patient se-
lection for inguinal lymphadenectomy, preventing 
unnecessary procedures or indicating earlier surgery 
when lymph nodes are not yet palpable(18,19).
 Although these novel noninvasive tests ap-
pear sensitive in preliminary reports, their ultimate 
value awaits further validation.
 One of our cases of lymphatic metastasis 
with a clinically negative region occurred in a patient 
with an undetected sentinel lymph node. This resulted 
in a 66% test sensitivity that was comparable with 
the literature and reinforced the need for surgical 
exploration of the inguinal region without lympho-
scintigraphic detection of the sentinel lymph node 
(4,5,20,21).
 Although the sentinel biopsy decreases the 
morbidity in penile cancer treatment, there are limita-
tions to a less aggressive approach and patients with 
undetected sentinel lymph node being considered a 
method limitation (22).
Table 1 – Cases studied and results obtained.
Patient Stage Grade Age Right Left Right Left Node Follow-up
1 PT2 II 60 excluded no captation excluded (-) N1 58
2 PT1 I 55 (-) (-) (-) (-) N0 55
3 PT2 I 50 (-) (-) (-) (-) N0 51
4 PT1 I 51 no captation (-) (-) (-) N0 47
5 PT1 I 63 (-) (-) (-) (-) N0 43
6 PT1 I 56 (-) (-) (-) (-) N0 33
7 PT2 I 44 (-) (-) (-) (-) N0 30
8 PT2 II 49 (-) (-) (-) (-) N0 29
9 PT2 I 81 (-) excluded (-) excluded N1 26
10 PT1 I 50 (-) (-) (-) (-) N0 24
11 PT2 I 45 (+) no captation (+) (+) N2 21
12 PT2 I 70 (-) no captation (-) (-) N0 19
13 PT2 I 52 (-) (-) (-) (-) N0 18
14 PT2 I 63 (-) no captation (-) (-) N0 15
15 PT2 II 65 (-) excluded (-) excluded N1 12
16 PT2 I 72 (-) (-) (-) (-) N0 10
17 PT3 II 66 excluded (+) excluded (+) N2 10
18 PT1 I 47 no captation (-) (-) (-) N0   8
57.7 28.3 (SD 16.2)
SD = standard deviation.
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 On the other hand, false-negative rate is 
encouraging and suggests that with experience and 
technical evolution lymphoscintigraphy could become 
a standard procedure requiring  further optimization 
at high volume centers.
 Taking into consideration that Catalona proce-
dure fails to identify until 15 % of patients developing 
late metastasis, new methods are warranted in the 
future (3).
 Considering the learning curve associated 
with lymphoscintigraphy and that penile cancer is a 
rare disease, the optimal lymphoscintigraphy tech-
nique is still in evolution, but it may  be a very good 
option in the future.
CONCLUSION
 Sentinel lymph node biopsy is a feasible 
method of assessing the presence of regional metasta-
sis in patients with penile cancer and clinically nega-
tive inguinal regions. It does not appear to decrease 
oncological outcomes.
 However, the optimal lymphoscintigraphy 
technique is still in evolution and requires further 
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access the risk of inguinal involvement, we now have a 
new instrument to guide the decisions. The nomogram 
of Ficarra et al. based on data of multicentric Italian 
group classify patients based in the most important 
prognostic factors as clinical lymph node stage and 
pathological data as tumor thickness, growth pattern, 
grade, lymphatic and vascular embolization, corpora 
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cavernosa and spongiosa infiltration (2). External 
validation for other populations is required for better 
acceptance of this instrument in clinical practice.
 Fifteen to 25% of these patients have micro-
metastatic disease at time of local treatment. Radical 
inguinal lymphadenectomy can be curative for low 
volume disease but the majority of patients will re-
ceive a surgical procedure with morbidity higher than 
50% (3). Wait and see policy has been advocate in the 
past but some recent data have showed that prophy-
lactic dissection offer survival advantage compared 
to rescue lymphadenectomy after clinical recurrence 
(4).
 Some authors suggest limited dissections. 
The reliability of this procedure had been questioned 
because some series reported up to 15% of late recur-
rence in other inguinal regions  from initial dissection 
(5).
 Anatomic sentinel lymph node as described 
by Cabanas has been abandoned because the high 
false negative results.
 Dynamic visualization of lymphatic drain-
age by blue dye in melanoma patients resulted in a 
renaissance of the sentinel node concept in penile 
cancer in the mid-1990s. Some recent data of refer-
ence centers world wide showed that this technique 
has reduced morbidity but controversy remains as 
regards oncological results. This technique requires 
that specialists in urology, pathology, and nuclear 
medicine collaborate closely, and high standards are 
also essential in quality control (6-8).
 The Netherlands data reported suggest that 
with constant improvements and standardization of 
the technique it proved possible to reduce the inci-
dence of false-negative results with experience (6). 
In cohort A (1994 until 2001), 21 of 157 explored 
groins contained tumor-positive sentinel nodes, and 
five false-negative procedures were encountered, re-
sulting in a false-negative rate of 19.2%. In cohort B 
(2001 until 2004), 20 of 105 explored groins contained 
tumor-positive sentinel nodes, and one procedure was 
false negative. The false-negative rate was 4.8%. The 
rate of complications dropped from 10.2% in cohort 
A to 5.7% in cohort B (1).
 Data from United Kingdom showed that in 
255 sentinel lymph node removed from 143 groins; 
all excised nodes had taken up the radioactive marker, 
and the blue dye was evident in 87%. Eighteen of 
75 (24%) patients and 21 of 143 groins (15%) had a 
positive sentinel. Six of 143 (4%) groins developed 
minor complications. Only one false-negative result 
was reported at a median (range) follow-up of 11 (2-
24) months (7).
 On the other hand, in the MD Anderson (8) 
experience 6 of 32 groins that showed drainage on 
preoperative lymphoscintigraphy had inguinal node 
metastasis, as did 1 of 10 that was drainage negative. 
The sensitivity of preoperative lymphoscintigraphy 
drainage for cancer detection was 86%. Using dy-
namic sentinel node biopsy with blue dye plus radio-
tracer 5 sentinel lymph nodes were positive for cancer, 
although 2 false-negative results were obtained. Thus, 
the sensitivity of dynamic sentinel node biopsy per 
groin for cancer detection was 71%. Authors believe 
that preoperative lymphoscintigraphy and dynamic 
sentinel node biopsy as currently performed remain 
insufficient for detecting occult inguinal disease. They 
suggest that superficial lymph node dissection remains 
the gold standard for detecting inguinal microscopic 
metastasis in these patients (8).
 The authors of this interesting manuscript 
consider that the false negative was 0% but 2 patients 
(11%) died of late inguinal recurrence in some area 
considered to have no metastasis. Due to the design of 
this study, we do not know which will be the outcome 
if patients when the sentinel was not detected would 
be received radical dissection.
 Conservative management of inguinal re-
gions have some particular problems in Brazilian 
population. Due to the low socio economic level of 
these patients, the follow up is not executed as rec-
ommended. We believe that the non detected cases at 
initial evaluation can result in loose the window of 
cure.
 Based in this discussion of the literature and 
considering that there are no ideal method to locate 
inguinal micrometastasis I and my colleagues of 
ABC Medical School proposed a radical dissection 
applying the principals of minimally invasive surgery. 
This procedure was designed to achieve reduction in 
morbidity without jeopardize the oncological control. 
Preliminary data obtained in 22 dissected groins in 
16 patients followed by 36 months showed reduced 
morbidity and no recurrence compared to open 
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conventional surgery (9). Other multicenter Latin 
America study has also showed the reduced morbidity 
of endoscopic approach (10).
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EDITORIAL COMMENT
 The manuscript reports on the value of senti-
nel lymph node biopsy using lymphoscintigraphy in 
patients with penile cancer and at least one negative 
inguinal region. Lymphoscintigraphy with peritumoral 
intradermal injection of technetium 99m was used to 
identify the sentinel lymph node. A comparative study 
using modified inguinal dissection was performed in 
these regions regardless of the biopsy results. I believe 
that it is an experimental method with 66% sensitivity, 
and 79.3 % specificity when compared with the modi-
fied inguinal lymphadenectomy in this manuscript. I 
agree with the authors´ conclusion that the optimal 
lymphoscintigraphy technique is still in evolution and 
requires further optimization at high volume centers. 
The manuscript is well written and the authors are to 
be congratulated for their interesting work.
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EDITORIAL COMMENT
 Sentinel lymph node biopsy (SLNB) is a 
novel diagnostic modality for the assessment of in-
guinal lymph nodes in penile cancer patients without 
palpable inguinal adenopathy. It offers the potential 
of reduced morbidity without compromising cancer 
detection accuracy as compared to modified inguinal 
lymph node dissection. However, while it is true some 
groups such as the Netherlands Cancer Institute (ref-
erences 7 and 11) have shown promising results with 
SLNB, its cancer detection accuracy has been shown 
to be operator dependent and associated with a steep 
learning curve. This is why the reported false negative 
rate for cancer detection has ranged from 0 to 22% 
(depending on the reported series). Before establish-
ing SLNB as the “gold standard” for the diagnostic 
evaluation of the inguinal region of penile cancer 
patients without palpable adenopathy, its results 
must be more consistently reported across multiple 
centers and its reduced morbidity versus modified 
inguinal lymph node dissection must be confirmed. 
Similarly, emerging diagnostic modalities including 
video endoscopic inguinal lymph node dissection and 
nanoparticle MRI may prove superior to SNLB in 
terms of cancer detection and surgical morbidity. As 
such, recent advances in radiologic imaging and mini-
mally invasive surgical approaches offer the potential 
to redefine the diagnostic and treatment standards for 
the management of penile cancer patients.
Dr. Philippe E. Spiess




REPLY BY THE AUTHORS
In the first editorial comment, the authors 
state in the 10th paragraph that 2 patients (11%) died 
of late inguinal recurrence in some area considered to 
have no metastasis. However, according to paragraph 
13 in results section of article, both patients presented 
positive groins at initial diagnosis and were submitted 
to radical lymphadenectomy. So, these patients were 
not considered as method fail.
We recommend radical lymphadenectomy 
when the sentinel lymph node was not detected, due to 
a possible erratic drainage caused by blockage due to 
a grossly involved impalpable metastatic lymph node. 
There are limitations to a less aggressive approach 
and patients with undetected sentinel lymph node 
are considered a method limitation, which explains 
in part 0% false negative and 66% sensitivity in the 
article. The optimal lymphoscintigraphy technique 
is still in evolution and requires further optimization 
associated with advances in radiologic imaging and 
minimally invasive surgical approaches. 
Emerging diagnostic modalities including 
video endoscopic inguinal lymph node dissection, 
nanoparticle MRI and sentinel lymph node biopsy 
may prove superior or either complementary among 
others in terms of cancer detection and surgical mor-
bidity.
The Authors
